drugset / Trial / NCT04648241
Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older
Non-randomizedParallel-groupOpen-labelPrevention
Summary
The main purpose of this study is to provide safety and immunogenicity data in Japanese participants.
Timeline
- Start
- 2021-01-18
- Primary completion
- 2022-02-21
- Completion
- 2022-02-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TBE vaccine | Vaccine | 0.25 ml | Intramuscular |
| Subject | TBE vaccine | Vaccine | 0.5 ml | Intramuscular |